"61958-1901-1" National Drug Code (NDC)

Genvoya 30 TABLET in 1 BOTTLE, PLASTIC (61958-1901-1)
(Gilead Sciences, Inc.)

NDC Code61958-1901-1
Package Description30 TABLET in 1 BOTTLE, PLASTIC (61958-1901-1)
Product NDC61958-1901
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameGenvoya
Non-Proprietary NameElvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide
Dosage FormTABLET
UsageORAL
Start Marketing Date20151105
Marketing Category NameNDA
Application NumberNDA207561
ManufacturerGilead Sciences, Inc.
Substance NameCOBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Strength150; 150; 200; 10
Strength Unitmg/1; mg/1; mg/1; mg/1
Pharmacy ClassesBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/61958-1901-1